人民卫生出版社系列期刊
ISSN 2096-2738 CN 11-9370/R

中国科技核心期刊(中国科技论文统计源期刊)
2020《中国学术期刊影响因子年报》统计源期刊

新发传染病电子杂志 ›› 2020, Vol. 5 ›› Issue (4): 253-257.doi: 10.19871/j.cnki.xfcrbzz.2020.04.008

• 论著 • 上一篇    下一篇

艾滋病合并淋巴结核患者疗效观察

宋树林1, 卢亦波1, 彭认平2, 张世迁1, 莫移美1, 周静如1   

  1. 1.南宁市第四人民医院,广西艾滋病临床治疗中心,广西医科大学附属传染病医院放射科,南宁,530023;
    2.南宁市第四人民医院,广西艾滋病临床治疗中心,广西医科大学附属传染病医院内镜室,南宁,530023
  • 收稿日期:2020-05-26 出版日期:2020-11-30 发布日期:2020-12-31
  • 通讯作者: 卢亦波,Email:13768415203@139.com
  • 基金资助:
    1.南宁市科学研究与技术开发计划基金资助项目(20173157-6);2.南宁市兴宁区科学研究与技术开发项目(2018A06)

Curative effect observation on anti-tuberculosis therapy for AIDS patients complicated with mediastinal lymph node tuberculosis

Song Shulin1, Lu Yibo1, Peng Renping2, Zhang Shiqian1, Mo Yimei1, Zhou Jingru1   

  1. 1. Department of Radiology,the Fourth People's Hospital of Nanning,Guangxi AIDS Clinical Treatment Center,Infectious Disease Hospital affiliated to Guangxi Medical University,Guangxi 530023,China;
    2. Department of Endoscopy Room,the Fourth People's Hospital of Nanning,Guangxi AIDS Clinical Treatment Center,Infectious Disease Hospital affiliated to Guangxi Medical University,Guangxi 530023,China
  • Received:2020-05-26 Online:2020-11-30 Published:2020-12-31

摘要: 目的 对比分析初治AIDS与非AIDS合并纵隔淋巴结结核患者纵隔淋巴结大小变化,评估AIDS合并纵隔淋巴结结核疗效。方法 本文搜集2016年1月至2019年12月南宁市第四人民医院AIDS合并纵隔淋巴结结核患者的临床及CT扫描资料作为观察组,搜集同时期非AIDS纵隔淋巴结结核患者的临床及CT资料作为对照组,淋巴结结核治疗采用2~3HRZE/9~15HRE方案。对比分析两组淋巴结结核患者化疗前临床表现,并通过抗结核过程中(1个月、2个月、4个月、6个月、8个月、12个月及以上)纵隔淋巴结大小变化情况对疗效进行评估。结果 两组患者性别、年龄差异无统计学意义。观察组MTB复合群检出率低于对照组,发热率较对照组高(P<0.001);治疗前CD4+T细胞显著低于对照组(Z=-5.565,P<0.001),首次住院时间较长(P=0.046)。咳嗽、咳痰差异均无统计学意义(P>0.05)。观察组血行播散性肺结核发生率(含继发性肺结核合并血行播散性肺结核)高于对照组(χ²=4.227,P=0.040)。两组患者抗结核1个月、2个月、4个月、6个月、8个月、12个月及以上治疗后疗效差异均无统计学意义(P>0.05)。观察组12例患者在高效抗逆转录病毒治疗(HAART)后7d至6个月后发生结核相关性免疫重建炎性综合征(TB-IRIS)而重复住院。结论 AIDS合并纵隔淋巴结结核与非AIDS合并纵隔淋巴结结核抗结核治疗具有相似疗效而不受HAART联合治疗的影响。CT随访可用于评估AIDS合并纵隔淋巴结结核疗效,特别是HAART的早期,有助于临床尽早对TB-IRIS作出诊断。

关键词: 获得性免疫缺陷综合征, 纵隔, 淋巴结结核, 疗效

Abstract: Objective To compare and analyze the size changes of primary treatment of tuberculosis of mediastinal lymph nodes in patients with AIDS and non-AIDS ,and to assess the efficacy of anti-tuberculous therapy in patients with AIDS combined with mediastinal lymph node tuberculosis.Methods Between January 2016 and December 2019,Clinical and CT scan data of patients with AIDS and non-AIDS combined with mediastinal nodal tuberculosis in Nanning Fourth People's Hospital were analyzed,and the patients of AIDS combined with mediastinal nodal tuberculosis as the observation group,the non-AIDS as the control group.The treatment of nodal tuberculosis was 2-3HRZE / 9-15HRE.Compared the clinical manifestations before the treatment between the two groups,Assessed the efficacy of anti-tuberculous therapy through observing the transformation of the lymph gland size at 1 month,2 month,4 month,6 month,8 month,12 month and above.Results There were no statistically significant differences in gender and age between the two groups.Before treatment,In observation group,the detection rate of MTB complex group was lower than the control group,the fever rate was higher (P<0.001),CD4+T cells were significantly lower (Z=-5.565,P<0.001),and the first hospital stay was longer (P=0.046).There were no statistically significant differences in cough and sputum (P>0.05).The incidence of hemoperatively disseminated pulmonary tuberculosis (including secondary pulmonary tuberculosis combined with hemoperatively disseminated pulmonary tuberculosis) in observation group was higher than that in control group (χ²=4.227,P=0.040).There was no statistically significant difference between the two groups in efficacy of anti-tuberculous therapy at 1Month,2Month,4Month,6Month,8Month,12Month or above (P>0.05).After 7 days-6months of Highly Active Antiretroviral Therapy (HAART),12 patients in observation group were repeatedly hospitalized because of tuberculosis-associated immune reconstruction syndrome (TB-IRIS).Conclusions The anti-tuberculosis treatment of AIDS patients combined with mediastinal lymph node tuberculosis and non-AIDS patients combined with mediastinal lymph node tuberculosis had similar efficacy and was not affected by HAART combined treatment.Follow-up with CT can be used to evaluate the anti-tuberculosis efficacy of AIDS patients combined with tuberculosis of mediastinal lymph nodes,especially in the early stage of HAART,which is conducive to the early clinical diagnosis of TB-associated immune reestablishment inflammatory syndrome.

Key words: Acquired immune deficiency syndrome, Mediastinum, Lymph node tuberculosis, Efficacy